Article Text

Download PDFPDF

Reactivation of Clostridium tertium bone infection 30 years after the Iran–Iraq war
Free
  1. Emilie Virot1,
  2. Elvire Servien1,2,
  3. Frederic Laurent1,2,3,
  4. Tristan Ferry1,2,3,
  5. on behalf of the Lyon Bone and Joint Infection Study Group
  1. 1Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
  2. 2Université Claude Bernard Lyon 1, Lyon, France
  3. 3Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, Lyon, France
  1. Correspondence to Dr Tristan Ferry, tristan.ferry{at}univ-lyon1.fr

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Description

A 40-year-old-man presented with left knee pain (during night and day) for 3 weeks. He has a history of left knee injury from shrapnel contracted in 1987 during the Iran–Iraq war (the patient did not experience cellulitis, loss of function or any other symptom immediately following the injury). At the time of physical examination 30 years later, a small curved scar facing the tibial tuberosity was seen, without fistula, without local signs of inflammation and without knee arthritis. X-ray showed bony lysis of the proximal tibia around a foreign metal object (figure 1A). CT scan combined with granulocyte-labelled scintigraphy showed recruitments of polymorphonuclear cells within the bone lysis (figure 1B). Tibiotomy was performed to extract the piece of shrapnel. A gentamicin-impregnated spacer was used to fill the bone cavity, which was later removed. Two of the four bone samples revealed late growth of Clostridium tertium, which was susceptible to penicillin. The patient received amoxicillin and pristinamycin during a course of 12 months. The evolution was favourable (figure 1C).

Figure 1

(A) X-ray of the tibia showing the foreign body and the bone lysis. (B) CT scan combined with granulocyte-labelled scintigraphy showing a recruitment of polymorphonuclear cells within the bone lysis. (C) X-ray of the tibia 3 years after the treatment.

C. tertium is a non-toxic aerotolerant Gram-positive bacillus that forms spores in aerobic conditions. It is often misidentified with Corynebacterium spp, Lactobacillus spp or Bacillus spp. C. tertium could be responsible for soft tissue infection or bacteraemia in immunocompromised hosts.1 ,2 Bone and joint infection due to C. tertium is rarely described in the literature. Greidlein et al3 reported 37 cases of septic arthritis due to the Clostridium species, including one case of C. tertium arthritis, which was also associated with a metal fragment. The management of implant-associated C. tertium infections requires extraction of the foreign body and prolonged antimicrobial therapy.

Learning points

  • Clostridium tertium could be responsible for late metal fragment bone and joint infection.

  • Late C. tertium metal fragment bone and joint infections requires a multidisciplinary management.

  • Late C. tertium metal fragment bone and joint infections requires metal extraction and prolonged antimicrobial therapy for healing.

References

View Abstract

Footnotes

  • Collaborators Lyon Bone and Joint Infection Study Group: Physicians—TF, Thomas Perpoint, André Boibieux, François Biron, Florence Ader, Julien Saison, Florent Valour, Fatiha Daoud, Johanna Lippman, Evelyne Braun, Marie-Paule Vallat, Patrick Miailhes, Christian Chidiac and Dominique Peyramond. Surgeons—Sébastien Lustig, Philippe Neyret, Olivier Reynaud, Caroline Debette, Adrien Peltier, Anthony Viste, Jean-Baptiste Bérard, Frédéric Dalat, Olivier Cantin, Romain Desmarchelier, Michel-Henry Fessy, Cédric Barrey, Francesco Signorelli, Emmanuel Jouanneau, Timothée Jacquesson, Pierre Breton, Ali Mojallal, Fabien Boucher and Hristo Shipkov. Microbiologists—FL, François Vandenesch, Jean-Philippe Rasigade and Céline Dupieux. Imaging—Loïc Boussel and Jean-Baptiste Pialat. Nuclear Medicine—Isabelle Morelec, Marc Janier and Francesco Giammarile. PK/PD specialists—Michel Tod, Marie-Claude Gagnieu and Sylvain Goutelle. Clinical Research Assistant—Eugénie Mabrut.

  • Contributors EV and TF wrote the case; ES participated in the patient's care and the literature review; FL participated to the literature review.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.